Cabaletta Bio, Inc. (CABA)
NASDAQ·Healthcare·Biotechnology
$1.42
—
Mkt Cap $272.97M
Analyst Ratings
Buy
2
Hold
2
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
Implied Upside
+1054.1%
Consensus $16.33 vs current $1.42
NASDAQ·Healthcare·Biotechnology
$1.42
—
Mkt Cap $272.97M
Buy
2
Hold
2
Sell
0
Price Target (3 analysts)
$16.33
Range $3.00 – $32.00
+1054.1%
Consensus $16.33 vs current $1.42